BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28789525)

  • 21. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
    Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
    Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
    Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
    J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.
    Dinter J; Duong E; Lai NY; Berberich MJ; Kourjian G; Bracho-Sanchez E; Chu D; Su H; Zhang SC; Le Gall S
    PLoS Pathog; 2015 Mar; 11(3):e1004725. PubMed ID: 25781895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction and identification of novel IBV S1 protein derived CTL epitopes in chicken.
    Tan L; Liao Y; Fan J; Zhang Y; Mao X; Sun Y; Song C; Qiu X; Meng C; Ding C
    Vaccine; 2016 Jan; 34(3):380-6. PubMed ID: 26620841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced expression of HLA-DM at the surface of dendritic cells increases loading of synthetic peptides on MHC class II molecules and modulates T cell responses.
    Pezeshki AM; Côté MH; Azar GA; Routy JP; Boulassel MR; Thibodeau J
    J Immunol; 2011 Jul; 187(1):74-81. PubMed ID: 21622867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles.
    Kawamura KS; Su RC; Nguyen LT; Elford AR; Ohashi PS; Gariépy J
    J Immunol; 2002 Jun; 168(11):5709-15. PubMed ID: 12023370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
    Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
    Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation peptide vaccines for advanced cancer.
    Yamada A; Sasada T; Noguchi M; Itoh K
    Cancer Sci; 2013 Jan; 104(1):15-21. PubMed ID: 23107418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation.
    Bijker MS; van den Eeden SJ; Franken KL; Melief CJ; van der Burg SH; Offringa R
    Eur J Immunol; 2008 Apr; 38(4):1033-42. PubMed ID: 18350546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune hierarchy among HIV-1 CD8+ T cell epitopes delivered by dendritic cells depends on MHC-I binding irrespective of mode of loading and immunization in HLA-A*0201 mice.
    Kloverpris HN; Karlsson I; Thorn M; Buus S; Fomsgaard A
    APMIS; 2009 Nov; 117(11):849-55. PubMed ID: 19845536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects.
    Indrová M; Reinis M; Bubeník J; Jandlová T; Bieblová J; Vonka V; Velek J
    Folia Biol (Praha); 2004; 50(6):184-93. PubMed ID: 15709713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles Vaccines Designed for Enhanced CD8
    Busch E; Kubon KD; Mayer JKM; Pidelaserra-Martí G; Albert J; Hoyler B; Heidbuechel JPW; Stephenson KB; Lichty BD; Osen W; Eichmüller SB; Jäger D; Ungerechts G; Engeland CE
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32098134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
    Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
    Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
    Mitsui H; Inozume T; Kitamura R; Shibagaki N; Shimada S
    J Invest Dermatol; 2006 Aug; 126(8):1804-12. PubMed ID: 16645583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer].
    Li Q; Zhang Y; Chen XH; Cao WX; Gu QL; Zhu ZG; Liu BY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):148-51. PubMed ID: 16555158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.
    Dinter J; Gourdain P; Lai NY; Duong E; Bracho-Sanchez E; Rucevic M; Liebesny PH; Xu Y; Shimada M; Ghebremichael M; Kavanagh DG; Le Gall S
    J Immunol; 2014 Nov; 193(9):4322-4334. PubMed ID: 25230751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.
    Chen X; Liu H; Tang Z; Yu Y; Zang G
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):203-12. PubMed ID: 23299079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
    De Haan L; Hearn AR; Rivett AJ; Hirst TR
    Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.